Brepocitinib | m-entrepreneurship.com

Product Name :
Brepocitinib

Search keywords :
Brepocitinib

drugId :
null

Target Vo:
Tyrosine-protein kinase 2

Target Vo Short Name :
TYK2

Moa_Name:
Tyrosine-protein kinase 2 inhibitors

First Approval Country :

First Approval Date Filter:
null

Origin Company_Name :
Pfizer Inc

Active Company_Name :
Pfizer Inc

Active Indication_Name:
Uveitis, Posterior

In Active Indication_Name:
Alopecia Areata

Termination Status :

China Termination Status :

Highest Status:
Phase 3 Clinical

China Highest Status:
Phase 2 Clinical

Antibodies are immunoglobulins secreted by effector lymphoid B cells into the bloodstream. Antibodies consist of two light peptide chains and two heavy peptide chains that are linked to each other by disulfide bonds to form a “Y” shaped structure. Both tips of the “Y” structure contain binding sites for a specific antigen. Antibodies are commonly used in medical research, pharmacological research, laboratory research, and health and epidemiological research. They play an important role in hot research areas such as targeted drug development, in vitro diagnostic assays, characterization of signaling pathways, detection of protein expression levels, and identification of candidate biomarkers.
Related websites: https://www.medchemexpress.com/antibodies.html
Popular product recommendations:
AKT1 Mouse mAb manufacturer
Met (C-Met) Rabbit mAb supplier
CD45 Antibody (YA533): CD45 Antibody (YA533) is a non-conjugated and Rabbit origined monoclonal antibody about 147 kDa., targeting to CD45. It can be used for WB,IHC-P,FC assays with tag free, in the background of Human.

Author: Betaine hydrochloride

Related Posts